Nephrotic syndrome and renal failure in a patient with metastatic breast cancer

Clinical and Experimental Nephrology

Volumn 15, Issue 4, 2011, Pages 567-571

  Yoshizawa, Hiromichi ^a   Akimoto, Tetsu ^a   Nishino, Katsuhiko ^a   Inoue, Makoto ^a   Ito, Chiharu ^a   Takeda, Shinichi ^a   Kotoda, Atsushi ^a   Tamba, Kaichiro ^a   Yumura, Wako ^a   Muto, Shigeaki ^a   Ueda, Yoshihiko ^b   Kusano, Eiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Breast cancer; Collapsing focal segmental glomerulosclerosis; Nephrotic syndrome; Pamidronate; Parietal epithelial cells

Indexed keywords

CAPECITABINE; DOCETAXEL; EXEMESTANE; LETROZOLE; PAMIDRONIC ACID; TAMOXIFEN;

ADULT; ARTICLE; BONE METASTASIS; BREAST CARCINOMA; CANCER MORTALITY; CASE REPORT; CELL HYPERPLASIA; CONTINUOUS INFUSION; DISEASE ASSOCIATION; DRUG WITHDRAWAL; EPITHELIUM CELL; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; HOSPITAL ADMISSION; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; NEPHROTIC SYNDROME; OSTEOLYSIS; PALLIATIVE THERAPY;

BONE NEOPLASMS; BREAST NEOPLASMS; DIPHOSPHONATES; FATAL OUTCOME; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; NEPHROTIC SYNDROME; RENAL INSUFFICIENCY;

EID: 80054744779     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-011-0425-1     Document Type: Article

References (28)

1. Bacchetta J, Juillard L, Cochat P, Droz JP. Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol. 2009;70:39-58
2. Perazella MA, Markowitz GS. Bisphosphonate nephrotoxicity. Kidney Int. 2008;74:1385-93
3. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, editor. Evaluation of chemotherapeutic agents. New York: Columbia University Press; 1949. p. 191-205
4. Hilner BE, Ingle JN, Chlebowski RT, Gralow J, Yee GC, Janjan NA, et al. American society of clinical oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol. 2003;21:4042-57 (Pubitemid 46606220)
5. Park IH, Ro J, Nam BH, Kwon Y, Lee KS. Potential antitumor effects of nitrogen-containing bisphosphonate in hormone receptor negative breast cancer patients with bone metastases. BMC Cancer. 2009;9:154
6. Wu S, Dahut WL, Gulley JL. The use of bisphosphonates in cancer patients. Acta Oncol. 2007;46:581-91 (Pubitemid 46911914)
7. Tralongo P, Repetto L, Di Mari A, Mauceri G, Bollina R, Ferrau F, et al. Safety of long-term administration of bisphosphonates in elderly cancer patients. Oncology. 2004;67:112-6 (Pubitemid 39482678)
8. Nadasdy T, Sedmak D. Acute and chronic tubulointerstitial nephritis. In: Jennette JC, Olson JL, Schwartz MM, Silvia FG, editors. Heptinstall's pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 1083-137
9. Smetana S, Michlin A, Rosenman E, Biro A, Boaz M, Katzir Z. Pamidronate-induced nephrotoxic tubular necrosis-a case report. Clin Nephrol. 2004;61:63-7 (Pubitemid 38100846)
10. Ronco PM. Paraneoplastic glomerulopathies: New insights into an old entity. Kidney Int. 1999;56:355-77 (Pubitemid 29300560)
11. Li YF, Fu S, Hu W, Liu JH, Finkel KW, Gershenson DM, et al. Systemic anticancer therapy in gynecological cancer patients with renal dysfunction. Int J Gynecol Cancer. 2007;17:739-63 (Pubitemid 47063315)
12. Launay-Vacher V, Gligorov J, Le Tourneau C, Janus N, Spano JP, Ray-Coquard I, et al. Breast Cancer Res Treat. 2010;124: 745-53
13. Lauro S, Lalle M, D'Andrea MR, Vecchione A, Frati L. Nephrotic syndrome and adjuvant treatment with tamoxifen for early breast cancer. Case report and review of the literature. Anticancer Res. 1994;15:2171-2
14. Barton CH, Vaziri ND, Spear GS. Nephrotic syndrome associated with adenocarcinoma of the breast. Am J Med. 1980;68:308-12 (Pubitemid 10169007)
15. Hill PA, Goodman DG, Snyder RD. Nephrotic syndrome associated with carcinoma of the breast. Clin Nephrol. 2003;60: 437-8 (Pubitemid 38196196)
16. Kijima Y, Yoshinaka H, Owaki T, Nozaki T, Hamada T, Yasumoto Y, et al. Breast cancer with nephrotic syndrome: Report of two cases. Surg Today. 2004;34:755-9 (Pubitemid 39208361)
17. Konoshita T, Itoh M, Hatakeyama S, Hirata M, Koni I, Miyazaki R, et al. Nephrotic syndrome due to focal glomerulosclerosis and undifferentiated carcinoma. Clin Nephrol. 2000;54:404-8
18. Loi S, Perry GJ, Standsich H, Dowling J. Glomerulosclerosis: A paraneoplastic phenomenon? Nephrology. 2004;9:387-91 (Pubitemid 40115964)
19. Markowitz GS, Fine PL, D'Agati VD. Nephrotic syndrome after treatment with pamidronate. Am J Kidney Dis. 2002;39:1118-22 (Pubitemid 34454233)
20. Sauter M, Jülg B, Jülg B, Porubsky, Cohen C, Fischereder M, Sitter T, et al. Nephrotic-range proteinuria following pamidronate therapy in a patient with metastatic breast cancer: Mitochondrial toxicity as a pathogenic concept? Am J Kidney Dis. 2006;47: 1075-80 (Pubitemid 43767326)
21. Tanvetyanon T, Stiff PJ. Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol. 2006;17:897-907 (Pubitemid 43785797)
22. Kriz W, Gretz N, Lemley KV. Progression of glomerular diseases: Is the podocyte the culprit? Kidney Int. 1998;54:687-97 (Pubitemid 28397387)
23. Nagata M, Hattori M, Hamano Y, Ito K, Saitoh K, Watanabe T. Origin and phenotypic features of hyperplastic epithelial cells in collapsing glomerulopathy. Am J Kidney Dis. 1998;32:962-9 (Pubitemid 28551158)
24. Kihara I, Yaoita E, Kawasaki K, Yamamoto M, Hara M, Yanagihara T. Origin of hyperplastic epithelial cells in idiopathic collapsing glomerulopathy. Histopathology. 1999;34:537-47 (Pubitemid 29284629)
25. Asano T, Niimura F, Pastan I, Fogo AB, Ichikawa I, Matsusaka T. Permanent genetic tagging of podocytes: Fate of injured podocytes in a mouse model of glomerular sclerosis. J Am Soc Nephrol. 2005;16:2257-62 (Pubitemid 41725042)
26. Dijkman HBPM, Weening JJ, Smeets B, Verrijp KCN, van Kuppevelt TH, Assmann KKJM, et al. Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. Kidney Int. 2006;70:338-44 (Pubitemid 44086583)
27. Bariéty J, Nochy D, Mandet C, Jacquot C, Glotz D, Meyrier A. Podocytes undergo phenotypic changes and express macrophagic- associated markers in idiopathic collapsing glomerulopathy. Kidney Int. 1998;53:918-25 (Pubitemid 28155664)
28. Barisoni L, Kriz W, Mundel P, D'Agati V. The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 1999;10:51-61. (Pubitemid 29034942)